SER - Serina Therapeutics, Inc.

5.8
0.130   2.241%

Share volume: 1,031
Last Updated: 05-06-2025
Pharmaceutical Products/Pharmaceutical Preparations: -0.13%

PREVIOUS CLOSE
CHG
CHG%
$5.67
0.13
0.02%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 03-31-2023 06-30-2023 09-30-2023 12-31-2023 03-31-2024 09-30-2024 12-31-2024
Fiscal Quarter Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q3 2024 Q4 2024
Report Date 05-12-2023 08-14-2023 11-14-2023 03-22-2024 05-14-2024 11-12-2024 03-24-2025
Total revenue 10.000 K 9.000 K 67.000 K 56.000 K 5.000 K 14.000 K -14.000 K
Cost of revenue 1.000 K 5.000 K 33.000 K 1.000 K 0.000 0.000 0.000
Gross profit 9.000 K 4.000 K 34.000 K 55.000 K 5.000 K 14.000 K -14.000 K
    -55.56% 750.00% 61.76% -90.91% 180.00% -200.00%  
Operating expenses 2.167 M 1.890 M 2.390 M 3.615 M 2.326 M 5.326 M 5.535 M
Selling general and admin 1.993 M 1.730 M 2.172 M 3.433 M 1.220 M 2.911 M 3.170 M
Research and development 174.000 K 160.000 K 218.000 K 182.000 K 1.106 M 2.415 M 2.365 M
Total expenses 2.168 M 1.895 M 2.423 M 3.616 M 2.326 M 5.326 M 5.535 M
    -12.59% 27.86% 49.24% -35.67% 128.98% 3.92%  
Operating income -2.158 M -1.886 M -2.356 M -3.560 M -2.321 M -5.312 M -5.549 M
Ebit -2.158 M -1.886 M -2.356 M -3.560 M -2.321 M 1.399 M -8.161 M
Pretax income -3.285 M -2.679 M -5.389 M -3.458 M -9.437 M 1.383 M -8.330 M
    -18.45% 101.16% -35.83% 172.90% -114.66% -702.31%  
Income tax 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Net income basic -3.277 M -2.669 M -5.401 M -3.456 M -9.437 M 0.000 0.000
    18.55% -102.36% 36.01% -173.06% 100.00%    
Net income -3.277 M -2.669 M -5.401 M -3.456 M -9.437 M 1.383 M -8.330 M
    18.55% -102.36% 36.01% -173.06% 114.66% -702.31%